Literature DB >> 7378122

The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects.

A L Catapano.   

Abstract

The apoC-II/apoC-III ratio and the distribution of C apoproteins as percentage of the total protein in VLDL obtained from normolipidemic and type IV patients was studied by analytical isoelectrofocusing. While the percentage concentration of apoCI-III was unchanged that of apoC-II was 9.2% of total protein in normal VLDL and only 7.4% in type IV VLDL (P less than 0.05). The apoC-II/apo C-III ratio significantly decreased in type IV patients. The analysis of VLDL subfractions obtained by density gradient ultracentrifugation gave essentially the same results. These data confirm the decrease of apoC-II as % of the protein in type IV VLDL and suggest that the decrease of the apoC-II/apoC-iii ratio in type IV patients is related only to the decreased content of apoC-II. Whether the reduced apoC-II percentage amount or the decreased apoC-II/apo C-III ratio are related to the hypertriglyceridemia in type IV subjects is still unclear.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378122     DOI: 10.1016/0021-9150(80)90182-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  [Apolipoproteinopathies].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1983-02-15

2.  Apolipoprotein C in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.

Authors:  A F Stalenhoef; P N Demacker; J A Lutterman; A van't Laar
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

3.  Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages.

Authors:  R L Klein; T J Lyons; M F Lopes-Virella
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

Review 4.  Lipoprotein sialylation in atherosclerosis: Lessons from mice.

Authors:  Liming Yu; Jun Peng; Chieko Mineo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.